New: Moderna Asked FDA To OK Vaccine Booster, 6 Months Shot Boosts Immunity, Study: NPR
Last edited Fri Sep 3, 2021, 09:18 PM - Edit history (3)
- NPR, Sept. 1, 2021.- Ed.
A third dose of the Moderna vaccine — given 6 months after the initial two doses — significantly boosts immunity, according to data the company submitted to the Food and Drug Administration on Wednesday.
The data comes from 344 volunteers who got an additional dose of the vaccine as part of a clinical study.
Antibodies had waned 6 months after vaccination, the company said, but the third shot boosted antibodies to an even higher point than was seen after the initial shots, even though the booster was just half the original dose.
The increased protection was "achieved across age groups, notably in older adults (ages 65 and above)," the company said.
Moderna made the announcement in a press release, but the research has not yet been peer-reviewed. Pfizer-BioNTech has also asked for authorization for a booster dose of its vaccine. The FDA has scheduled a meeting for September 17th to discuss the need for boosters for the general population.
The FDA and the Centers for Disease Control and Prevention have already recommended a third dose of both the Pfizer and Moderna vaccines for some immunocompromised people. Meanwhile, health officials are already preparing to roll out COVID-19 boosters, according to a plan announced by the White House on August 18th.
The plan calls for all adults who received a two-dose vaccine to be eligible for an additional jab 8 months from when they got their second shot.
But that decision isn't actually final yet. The FDA and the CDC's Advisory Committee on Immunization Practices (ACIP) first need to OK the move...
More,
https://www.npr.org/sections/coronavirus-live-updates/2021/09/01/1033474298/moderna-fda-covid-19-booster-shot
